Serdia Pharmaceuticals India

Servier India (formerly known as Serdia Pharmaceuticals India) is the Indian subsidiary of the French multinational pharmaceutical company Les Laboratoires Servier. Established in 1985, the company specializes in the development, manufacturing, and marketing of pharmaceutical products, with a primary focus on cardiometabolism, venous diseases, neuroscience, and oncology. Its well-known commercial portfolio in India includes brands such as Coversyl (perindopril) for hypertension, Diamicron (gliclazide) for type 2 diabetes, Coralan (ivabradine) for angina and heart failure, and Daflon for venous diseases. Servier India operates with a strong ethical promotion model and collaborates closely with healthcare professionals across the country to improve patient access to innovative therapies.